These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 4435008)
61. The influence of acetylsalicyclic acid on the binding of acetrizoate to human albumin. Pinckard RN; Hawkins D; Farr RS Ann N Y Acad Sci; 1973 Nov; 226():341-54. PubMed ID: 4520401 [No Abstract] [Full Text] [Related]
62. Interaction of cytotoxic dibromohexitols with albumin. Institoris E; Holczinger L Biochem Pharmacol; 1971 Jun; 20(6):1183-9. PubMed ID: 5118116 [No Abstract] [Full Text] [Related]
63. Drug protein conjugates--I. A study of the covalent binding of [14C]captopril to plasma proteins in the rat. Park BK; Grabowski PS; Yeung JH; Breckenridge AM Biochem Pharmacol; 1982 May; 31(9):1755-60. PubMed ID: 7049181 [TBL] [Abstract][Full Text] [Related]
64. Systemic absorption of delta 9-tetrahydrocannabinol after ophthalmic administration to the rabbit. Chiang CW; Barnett G; Brine D J Pharm Sci; 1983 Feb; 72(2):136-8. PubMed ID: 6300368 [TBL] [Abstract][Full Text] [Related]
65. Metabolism and disposition of hydralazine-14C in man and dog. Lesser JM; Israili ZH; Davis DC; Dayton PG Drug Metab Dispos; 1974; 2(4):351-60. PubMed ID: 4153405 [No Abstract] [Full Text] [Related]
66. Relating Observed Psychoactive Effects to the Plasma Concentrations of Delta-9-Tetrahydrocannabinol and Its Active Metabolite: An Effect-Compartment Modeling Approach. Awasthi R; An G; Donovan MD; Boles Ponto LL J Pharm Sci; 2018 Feb; 107(2):745-755. PubMed ID: 28942005 [TBL] [Abstract][Full Text] [Related]
67. Physiological disposition of 2,6-dimethyl-4-benzyl-4-demethylrifampicin in rats, mice, and dogs. Wolpert MK; Lu K; Derr CJ; Loo TL; Johns DG Drug Metab Dispos; 1974; 2(3):237-46. PubMed ID: 4153001 [No Abstract] [Full Text] [Related]
68. [Absorption, distribution, metabolism and excretion of netilmicin in rats (III). Metabolic fate of 14C-netilmicin after intramuscular administration (author's transl)]. Uda F; Fujino A; Tokiwa T Jpn J Antibiot; 1982 Apr; 35(4):967-78. PubMed ID: 7097991 [TBL] [Abstract][Full Text] [Related]
69. The uptake of delta9-tetrahydrocannabinol in choroid plexus and brain cortex in vitro and in vivo. Agnew WF; Rumbaugh CL; Cheng JT Brain Res; 1976 Jun; 109(2):355-66. PubMed ID: 1276919 [TBL] [Abstract][Full Text] [Related]
70. Transformation of delta-1-tetrahydrocannabinol (THC) by rabbit liver microsomes. Ben-Zvi Z; Burstein S Biochem Pharmacol; 1975 May; 24(10):1130-1. PubMed ID: 1156437 [No Abstract] [Full Text] [Related]
71. Cannabinol-7-oic acid: a metabolite of delta1-tetrahydrocannabinol in the rhesus monkey. Ben-Zvi Z; Bergen JR; Burstein S Res Commun Chem Pathol Pharmacol; 1974 Sep; 9(1):201-4. PubMed ID: 4216059 [No Abstract] [Full Text] [Related]
72. Pharmacokinetic properties of delta9-tetrahydrocannabinol in oral fluid of occasional and chronic users. Toennes SW; Ramaekers JG; Theunissen EL; Moeller MR; Kauert GF J Anal Toxicol; 2010 May; 34(4):216-21. PubMed ID: 20465868 [TBL] [Abstract][Full Text] [Related]
73. Binding of drugs to plasma proteins of swine during the perinatal period. Short CR; Tumbleson ME Toxicol Appl Pharmacol; 1973 Apr; 24(4):612-24. PubMed ID: 4713484 [No Abstract] [Full Text] [Related]
74. [Metabolic fate of 14C-isepamicin sulfate (14C-HAPA-B) in rats. I. Absorption, distribution, metabolism and excretion after a single intramuscular and intravenous administration]. Iwasaki M; Serizawa K; Suzuki T; Morishita M; Takahashi T; Muranishi S Jpn J Antibiot; 1987 Jan; 40(1):239-52. PubMed ID: 3586333 [TBL] [Abstract][Full Text] [Related]
75. Comparison between self-report of cannabis use and toxicological detection of THC/THCCOOH in blood and THC in oral fluid in drivers in a roadside survey. Van der Linden T; Silverans P; Verstraete AG Drug Test Anal; 2014; 6(1-2):137-42. PubMed ID: 23939912 [TBL] [Abstract][Full Text] [Related]
76. Systemic excretion of benzo(a)pyrene in the control and microsomally induced rat: the influence of plasma lipoproteins and albumin as carrier molecules. Shu HP; Bymun EN Cancer Res; 1983 Feb; 43(2):485-90. PubMed ID: 6293698 [TBL] [Abstract][Full Text] [Related]
77. Assessment of driving capability through the use of clinical and psychomotor tests in relation to blood cannabinoids levels following oral administration of 20 mg dronabinol or of a cannabis decoction made with 20 or 60 mg Delta9-THC. Ménétrey A; Augsburger M; Favrat B; Pin MA; Rothuizen LE; Appenzeller M; Buclin T; Mangin P; Giroud C J Anal Toxicol; 2005; 29(5):327-38. PubMed ID: 16105257 [TBL] [Abstract][Full Text] [Related]
78. Radioimmunoassay of cannabinoids in blood and urine. Teale JD; Forman EJ; King LJ; Marks V Lancet; 1974 Sep; 2(7880):553-5. PubMed ID: 4140271 [TBL] [Abstract][Full Text] [Related]
79. Population pharmacokinetics model of THC used by pulmonary route in occasional cannabis smokers. Marsot A; Audebert C; Attolini L; Lacarelle B; Micallef J; Blin O J Pharmacol Toxicol Methods; 2017; 85():49-54. PubMed ID: 28167229 [TBL] [Abstract][Full Text] [Related]
80. Nonsmoker Exposure to Secondhand Cannabis Smoke. III. Oral Fluid and Blood Drug Concentrations and Corresponding Subjective Effects. Cone EJ; Bigelow GE; Herrmann ES; Mitchell JM; LoDico C; Flegel R; Vandrey R J Anal Toxicol; 2015 Sep; 39(7):497-509. PubMed ID: 26139312 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]